Application Nr Approved Date Route Status External Links
ANDA075280 2002-02-25 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carefully Consider The Potential Benefits And Risks Of Nabumetone Tablets Usp And Other Treatment Options Before Deciding To Use Nabumetone Tablets Usp. Use The Lowest Effective Dose For The Shortest Duration Consistent With Individual Patient Treatment Goals (see Warnings ). Nabumetone Tablets Usp Are Indicated: * For Relief Of The Signs And Symptoms Of Rheumatoid Arthritis. * For Relief Of The Signs And Symptoms Of Osteoarthritis.

All Formulated Excipients (6 Total)

Name Structure Kind Function Status
1. Croscarmellose Sodium CROSCARMELLOSE SODIUM Unresolved
2. Hypromelloses HYPROMELLOSES Unresolved
3. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
4. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
5. Titanium Dioxide TITANIUM DIOXIDE Unresolved DYE-Dye
6. Polyethylene Glycol 400 POLYETHYLENE GLYCOL 400 Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Nabumetone NABUMETONE ZINC20221